Global Resistance of Neisseria gonorrhoeae
Global Resistance of Neisseria gonorrhoeae
Despite the need for new antimicrobial treatment options, no such agents are in the late development stage. Pleuromutilins, novel inhibitors of bacterial topoisomerases and efflux pumps, FabI inhibitors and LpxC inhibitors are among compounds that may potentially be exploited to improve the management of MDR/XDR gonorrhoea in the future.
Antimicrobial Treatment Options in Development
Despite the need for new antimicrobial treatment options, no such agents are in the late development stage. Pleuromutilins, novel inhibitors of bacterial topoisomerases and efflux pumps, FabI inhibitors and LpxC inhibitors are among compounds that may potentially be exploited to improve the management of MDR/XDR gonorrhoea in the future.